| 000 | 01581 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250517231617.0 | ||
| 264 | 0 | _c20190204 | |
| 008 | 201902s 0 0 eng d | ||
| 022 | _a1932-6203 | ||
| 024 | 7 |
_a10.1371/journal.pone.0201556 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aOnchieku, Noah Machuki | |
| 245 | 0 | 0 |
_aDeciphering the targets of retroviral protease inhibitors in Plasmodium berghei. _h[electronic resource] |
| 260 |
_bPloS one _c2018 |
||
| 300 |
_ae0201556 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnti-Retroviral Agents _xchemistry |
| 650 | 0 | 4 |
_aAntimalarials _xpharmacology |
| 650 | 0 | 4 |
_aAspartic Acid Endopeptidases _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aAspartic Acid Proteases _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aLopinavir _xchemistry |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aModels, Molecular |
| 650 | 0 | 4 | _aMolecular Docking Simulation |
| 650 | 0 | 4 |
_aPlasmodium berghei _xdrug effects |
| 650 | 0 | 4 |
_aProtease Inhibitors _xchemistry |
| 650 | 0 | 4 |
_aProtozoan Proteins _xantagonists & inhibitors |
| 650 | 0 | 4 | _aReverse Genetics |
| 650 | 0 | 4 |
_aSaquinavir _xchemistry |
| 700 | 1 | _aMogire, Reagan | |
| 700 | 1 | _aNdung'u, Loise | |
| 700 | 1 | _aMwitari, Peter | |
| 700 | 1 | _aKimani, Francis | |
| 700 | 1 | _aMatoke-Muhia, Damaris | |
| 700 | 1 | _aKiboi, Daniel | |
| 700 | 1 | _aMagoma, Gabriel | |
| 773 | 0 |
_tPloS one _gvol. 13 _gno. 8 _gp. e0201556 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1371/journal.pone.0201556 _zAvailable from publisher's website |
| 999 |
_c28690834 _d28690834 |
||